In ovo evaluation of antiviral effects of aqueous garlic (Allium sativum) extract against a velogenic strain of Newcastle disease virus

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 30

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HERM-9-3_007

تاریخ نمایه سازی: 26 بهمن 1402

Abstract:

Introduction: The antiviral property of aqueous garlic extract against a virulent velogenic field isolate of Newcastle disease virus (NDV) was investigated in a time of addition assay in embryonated chicken eggs (ECEs). Methods: The ECEs were inoculated with the lowest concentration of the virus with HA (haemagglutination) positive activity. After determination of extract toxicity in ECEs, administration of different concentrations of the extract (۰.۵, ۱, ۲, ۴ mg/mL) or ribavirin (comparative control) was performed ۸ hours before (pretreatment), simultaneously (cotreatment) or ۸ hours after (post treatment) virus injection. Allantoic fluids were harvested for infectivity determination, transmission electron microscopy (TEM) and viral load (HA titer) assay. In vitro HA blocking activity test was also performed. Results: Allicin content of the extract was ۱۶.۶% by HPLC method. The best viability results were related to the extract in pretreatment and ribavirin in co-treatment trials (p<۰.۰۵ as compared to infected ECEs with no treatment). Pre and co-treatment assays showed better results on HA titer of garlic treated groups. In infectivity assay, the ۵۰% embryo lethal dose (ELD۵۰) values of NDV were roughly ۵۰۰ and ۵۰ folds of ELD۵۰ of the untreated virus in pre and co-treatment, respectively. No change was observed in viral shapes in TEM analysis nor HA blocking activity in vitro. Conclusion: Aqueous extract of garlic shows antiviral effects against a velogenic strain of NDV in ovo accompanied by a reduction in virus infectivity and titer. These effects are most pronounced in pretreatment trial.